The Western New York Brain Tumor Center
The Western New York Neuro Oncology Center, established in 2002, is a collaboration between Roswell Park Cancer Institute and The Dent Neurologic Institute, which offers the highest quality clinical care and innovative research in neuro-oncology.
Members of the Western New York Neuro-oncology team treat patients with many different types of tumors that arise from the brain, spine and pituitary gland.
The Western New York Neuro-oncology Center provides a full spectrum of clinical services to patients with benign and malignant tumors of the brain and spine. Treatment options include conventional and computer-assisted neurosurgery, micro-neurosurgery, Gamma Knife radiosurgery, radiation therapy and chemotherapy.
Neuro-oncologists study and treat cancers of the nervous system (brain, spine and pituitary gland). These physicians, researchers and their support teams advance the care of patients with brain and spinal tumors by delivering the most effective treatments available with the goal of maintaining each patient's quality of life. A multi-disciplinary team of neuro-oncologic specialists works jointly to diagnose and treat patients with cancers and benign tumors of the nervous system.
Gliomas and metastatic brain tumors are the most common brain tumors treated by neuro-oncologists. Gliomas are "primary" brain tumors that arise in the brain itself and rarely spread to other organs. Metastatic tumors are "secondary" tumors that arise in other organs such as the breast, lung, skin, kidney and colon and spread to the brain by way of the bloodstream. Brain tumors represent a diverse group of diseases that behave in different ways and grow at different rates. Consequently, it is very important to distinguish carefully between the different types of brain tumors when evaluating any patient's condition and treatment options.
Some brain tumors are able to be kept in remission for long periods by surgical excision or radiation therapy, while others may continue to grow, despite extensive treatment. Consequently, there may be wide variation between individual patients in terms of tumor behavior and response to treatment.